semaglutide and methylcobalamin / Cyanocobalamin Injection semaglutide/methylcobalamin injection Semaglutide Microdose

The name change capitalizes on the brand-name recognition of Ozempic , which has been available for subcutaneous administration in patients with type 2 diabetes since 2017

Both medications share similar gastrointestinal side effects: nausea, diarrhea, vomiting, and decreased appetite

2 Moreover, taking semaglutide can increase the chance of developing thyroid tumors, including medullary thyroid carcinoma

If your doctor suggests continuing the medication despite your symptoms, consider seeking a second opinion from specialists familiar with the adverse effects of GLP-1 drugs

Patients also show strong interest in oral formulations rather than injectable treatments